Back to top

Image: Bigstock

Compared to Estimates, Leidos (LDOS) Q1 Earnings: A Look at Key Metrics

Read MoreHide Full Article

For the quarter ended March 2026, Leidos (LDOS - Free Report) reported revenue of $4.4 billion, up 3.7% over the same period last year. EPS came in at $3.13, compared to $2.97 in the year-ago quarter.

The reported revenue represents a surprise of +3.12% over the Zacks Consensus Estimate of $4.27 billion. With the consensus EPS estimate being $2.88, the EPS surprise was +8.56%.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

Here is how Leidos performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
  • Revenue- Defense: $883 million versus the two-analyst average estimate of $931.98 million.
  • Revenue- Homeland: $816 million versus the two-analyst average estimate of $781.7 million.
  • Revenue- Health: $1.19 billion versus $1.12 billion estimated by two analysts on average.
  • Revenue- Intelligence & Digital: $1.51 billion versus $1.46 billion estimated by two analysts on average.
  • Non-GAAP operating income- Intelligence & Digital: $155 million compared to the $149.92 million average estimate based on two analysts.
  • Non-GAAP operating income- Defense: $73 million versus the two-analyst average estimate of $93.34 million.
  • Non-GAAP operating income- Homeland: $69 million compared to the $75.13 million average estimate based on two analysts.
  • Non-GAAP operating income- Health: $288 million versus the two-analyst average estimate of $250.63 million.

View all Key Company Metrics for Leidos here>>>

Shares of Leidos have returned -6.7% over the past month versus the Zacks S&P 500 composite's +9.5% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

Zacks' 7 Best Strong Buy Stocks (New Research Report)

Valued at $99, click below to receive our just-released report predicting the 7 stocks that will soar highest in the coming month.

Click Here, It's Really Free

Published in